A gel separates, a probe adds complementarity, selection enriches candidates, and sequencing produces evidence with quality and mapping limits. Keep those roles distinct.
01
LESSON 1 · 22 MIN
Study + retrieve
Amplify, separate, and identify
Choose PCR, reverse transcription, electrophoresis, or a complementary probe by matching each method to the molecule, transformation, and claim in the prompt.
ESSENTIAL QUESTIONDoes the question require more copies, size separation, or sequence-specific identification?
STUDY DIAGRAM · TEXT DESCRIPTION AVAILABLE
01
Match the template to the question
PCR amplifies the DNA interval flanked by two compatible primers through repeated denaturation, primer annealing, and extension. If the starting evidence is RNA, reverse transcriptase first makes complementary DNA, or cDNA, before DNA amplification. Detecting cDNA can support that an RNA was present, but sample quality and controls still matter.
DNA target → PCR
RNA evidence → reverse transcription → cDNA
Primers bound the amplified interval
02
Read migration as size evidence
Nucleic acids carry negative charge and migrate toward the positive electrode in a gel. Under the supplied gel conditions, smaller fragments move through the matrix farther than larger fragments. A size ladder supports a fragment-length estimate; equal migration does not prove equal sequence.
Smaller fragments usually travel farther
Compare with a size ladder
Same size can hide different sequences
03
Add specificity deliberately
A labeled probe can hybridize to a complementary target sequence after fragments are separated and transferred or otherwise made accessible. The probe supplies sequence-specific evidence that the gel alone lacks. Southern-style evidence concerns DNA, while an RNA-targeting assay can address transcript presence or abundance under the stated conditions.
Separation asks how far
Probe asks complementary to what
Method readout bounds the claim
Worked example
Two DNA fragments migrate to the same gel position, but only one binds a labeled probe complementary to sequence Q. What can be concluded?
1
Equal migration supports similar fragment size under the gel conditions.
2
Probe binding supplies sequence-specific evidence for Q in one band.
3
The gel position alone cannot identify either complete sequence.
ConclusionThe probe-positive fragment contains a complementary Q target under the assay conditions; equal gel position by itself did not establish sequence identity.
Close the notes first
Retrieve the evidence boundary.
01What defines the main PCR product?
The DNA interval flanked by the two primers.
Extension from both primers enriches the bounded target through repeated cycles.
02Why reverse-transcribe RNA before ordinary PCR?
Ordinary PCR uses DNA templates, so RNA is first converted to cDNA.
Reverse transcriptase bridges the RNA question to DNA amplification.
03Does one gel band reveal its exact sequence?
No; migration primarily supplies size evidence under the gel conditions.
Different sequences can produce fragments of similar length.
02
LESSON 2 · 23 MIN
Study + retrieve
Construct, select, edit, verify
Trace recombinant DNA and targeted editing while keeping delivery, selection, molecular verification, and functional validation separate.
ESSENTIAL QUESTIONWhich step creates the construct, which enriches candidate cells, and which confirms the intended molecular result?
STUDY DIAGRAM · TEXT DESCRIPTION AVAILABLE
01
Build the construct in order
Restriction enzymes can generate defined DNA ends, compatible insert and vector ends can anneal, and DNA ligase seals phosphodiester bonds. A useful vector carries the insert and features needed for propagation or selection. The recombinant vector must then enter a host before candidate transformed cells can be recovered.
Cut compatible ends
Ligate insert into vector
Transform host before recovery
02
Do not confuse selection with verification
A selectable marker enriches cells with the selected phenotype, such as survival under a stated condition. It does not prove insert orientation, complete sequence, copy number, or absence of unintended changes. Screening and sequence-level verification answer those later questions.
Selection enriches candidates
Screening distinguishes candidates
Sequence confirms exact bases
03
Separate targeting from repair outcome
In a supplied CRISPR-style model, a guide helps direct a nuclease to a compatible target. Cutting is followed by cellular repair, which can create different outcomes. Delivery, on-target change, mosaic or mixed products, off-target changes, and phenotype are distinct checkpoints rather than one guaranteed result.
Guide supports targeting
Repair determines edit outcome
Verify on-target and unintended change
Worked example
Colonies survive selection after transformation with a vector designed to carry insert X. Is survival enough to prove a perfect X construct?
1
Survival shows that the selectable phenotype is present under the stated condition.
2
The marker can be present even if X is absent, rearranged, reversed, or otherwise incorrect.
3
A screen followed by sequence verification is needed for the exact construct claim.
ConclusionSelection enriches candidate transformants; it does not replace molecular verification of insert X.
Close the notes first
Retrieve the evidence boundary.
01What does DNA ligase do in a cloning model?
It covalently joins compatible DNA fragments by sealing the backbone.
Base pairing aligns ends, while ligase completes the phosphodiester linkage.
02What does selectable survival prove?
The selected phenotype is present under the assay conditions.
It does not by itself reveal the complete construct sequence.
03Does a targeted nuclease guarantee one exact edit?
No; cellular repair can generate multiple outcomes, and delivery and off-target effects require verification.
Target recognition and final genotype are separate stages.
03
LESSON 3 · 23 MIN
Study + retrieve
Controls, coverage, and validation
Judge a sequencing or detection result using control behavior, read quality, coverage, mapping ambiguity, contamination risk, and independent validation.
ESSENTIAL QUESTIONDid the controls behave, is the signal supported repeatedly and unambiguously, and can an independent test challenge the same claim?
STUDY DIAGRAM · TEXT DESCRIPTION AVAILABLE
01
Make controls carry information
A positive control should produce the expected signal and shows that the detection workflow can work. A negative control should lack the target signal and can expose contamination or nonspecific detection. If either control fails, the sample result may be uninterpretable rather than simply positive or negative.
Positive control tests detection
Negative control tests background
Failed control can invalidate the run
02
Read beyond one sequence read
A single read can contain base-calling error, originate from contamination, or align ambiguously. Repeated high-quality support, adequate coverage, agreement across strands or fragments, and unambiguous mapping increase confidence. High average coverage does not guarantee every position is covered evenly.
One read is weak evidence
Coverage can be uneven
Repeats can create mapping ambiguity
03
Validate through independence
Technical replication repeats a workflow and can test consistency, while orthogonal validation uses an independent method or sample to test the same biological claim. Sample identity, amplification bias, contamination, mapping, and sampling remain separate possible failure points.
Replication checks consistency
Orthogonal method changes failure mode
Claim must survive relevant controls
Worked example
One low-quality read supports variant V, while 40 high-quality reads support the reference base. A negative control also contains one V read. What is the best interpretation?
1
The sample has weak, isolated support for V and strong support for the reference.
2
The V signal in the negative control raises contamination or artifact concern.
3
The variant claim should not be accepted without a clean repeat and independent validation.
ConclusionThe evidence is insufficient for V; control contamination and one-read support outweigh a definitive-variant conclusion.
Close the notes first
Retrieve the evidence boundary.
01What does a failed positive control imply?
The assay may not have detected a target it should detect, so sample negatives may be uninterpretable.
A broken detection workflow can mimic absence.
02Why can one read be misleading?
It may reflect error, contamination, or ambiguous alignment.
Variant confidence depends on quality, repeated support, coverage, and mapping.
03What makes validation orthogonal?
It tests the same claim using an independent method or sample with different failure modes.
Independent evidence reduces reliance on one technical artifact.
Randomized retrieval set
Now choose the tool, interpret the control, or identify the missing verification.
PCR, reverse transcription, gels, probes, cloning, selection, targeted editing, coverage, contamination, and validation are interleaved.
12 PRACTICE QUESTIONS
Retrieve before you review.
Question order and all five answer options are shuffled when you begin. The correct answer stays attached to the same underlying choice.
Scope and score notice
Genetic Technology foundations, not laboratory or clinical instruction.
The ADA lists genetic technology within Genetics but does not publish a subtopic item quota. DAT TRAIN does not invent one.
Laboratory recipes, platform engineering, clinical gene-therapy decisions, personal genetic interpretation, and regulatory approval remain outside this route.
Use your results to choose what to review next—not as an official DAT score prediction.